scispace - formally typeset
N

Natasha J. Caplen

Researcher at National Institutes of Health

Publications -  110
Citations -  11118

Natasha J. Caplen is an academic researcher from National Institutes of Health. The author has contributed to research in topics: RNA interference & Gene silencing. The author has an hindex of 41, co-authored 103 publications receiving 10682 citations. Previous affiliations of Natasha J. Caplen include Imperial College London.

Papers
More filters
Journal ArticleDOI

Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems.

TL;DR: Synthetic siRNAs can induce gene-specific inhibition of expression in Caenorhabditis elegans and in cell lines from humans and mice, and seem to avoid the well documented nonspecific effects triggered by longer double-stranded RNAs in mammalian cells.
Journal ArticleDOI

Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.

TL;DR: A partial restoration of the deficit between CF and non-CF subjects of 20% was seen for the response to low Cl− perfusion following CFTR cDNA administration and it is likely that transfection efficiency and the duration of expression will need to be increased for therapeutic benefit.
Journal ArticleDOI

Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells

TL;DR: The data suggest that siRNAs can induce nonspecific effects on protein levels that are siRNA sequence dependent but that these effects may be difficult to detect until genes central to a pivotal cellular response, such as p53 and p21, are studied.
Journal ArticleDOI

Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

TL;DR: Overall, a range of correction was seen with restoration of about 50% of the deficit between wild type mice and untreated cf/cf controls, suggesting that this may offer a therapeutic alternative to adenoviral therapies.